Form 8-K - Current report:
SEC Accession No. 0001396814-25-000017
Filing Date
2025-01-21
Accepted
2025-01-21 08:05:03
Documents
18
Period of Report
2025-01-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20250116.htm   iXBRL 8-K 34339
2 EX-10.1 ex101-ar2014inducementplan.htm EX-10.1 92994
3 EX-10.2 ex102-ar2014inducementplan.htm EX-10.2 26832
4 EX-10.3 ex103-ar2014inducementplan.htm EX-10.3 38088
5 EX-99.1 pcrx-newccopressreleasejan.htm EX-99.1 30650
9 PACIRA BIOSCIENCES LOGO paciralogo2025a.jpg GRAPHIC 82257
  Complete submission text file 0001396814-25-000017.txt   505732

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20250116.xsd EX-101.SCH 1792
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20250116_lab.xml EX-101.LAB 22771
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20250116_pre.xml EX-101.PRE 13050
21 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20250116_htm.xml XML 2830
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 25540483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)